Market Tracker

10/24 6:05pm ET

Geron Corp (NASDAQ:GERN)

2.23
Data as of Oct 24
 +0.02 / +0.90%
Today’s Change
1.31
Today|||52-Week Range
7.36
-50.21%
Year-to-Date

Today’s Trading

Previous close2.21
Today’s open2.20
Day’s range2.17 - 2.24
Volume1,661,606
Average volume (3 months)1,977,201
Market cap$349.9M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+23.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC+0.22+1.37%
OXFDOxford Immunotec Glo...-0.01-0.07%
TTHITransition Therapeut...+0.02+0.31%
CALACalithera Bioscience...+1.14+11.52%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts